Should I Buy ANAB Stock in 2026?
Data-driven analysis and honest assessment for Anaptysbio Inc
Current Price: $55.67
Decision Score
Weak
Based on 6 fundamental factors
Score Breakdown:
P/E data not available
Declining -0%
Currently unprofitable
Financial health data limited
Low FCF yield of 1.7%
No recent insider activity
Key Investment Metrics
Current Price
$55.67
P/E Ratio
N/A
Revenue Growth
-0.1%
Profit Margin
-0.1%
Market Cap
$1.7B
Dividend Yield
None
How ANAB Compares to Competitors
Understanding how ANAB stacks up against peers helps inform your investment decision.
How ANAB Compares to Peers
Upcoming Events for ANAB
+5 Reasons TO Buy ANAB
Limited data available to identify compelling buy reasons. Consider this a yellow flag.
-5 Reasons NOT to Buy ANAB
1. Company is not profitable
high riskCurrently losing money. May need to raise capital or cut operations.
2. Revenue declining 0%
medium riskShrinking revenue suggests loss of market share or weakening demand. Turnarounds are difficult.
3. Small-cap volatility risk
medium riskMarket cap under $2B means higher volatility and lower liquidity.
4. Low free cash flow yield of 1.7%
low riskLimited cash generation means most value comes from future growth expectations.
Who Should Buy ANAB?
Investment Profile
Risk Level
Very High
Recommended Holding Period
5+ years (turnaround required)
Best For:
Not Suitable For:
- ✗
Growth Investors
Limited -0% growth may disappoint
- ✗
Income-Focused Retirees
No dividend paid
- ✗
Risk-Averse Investors
Very High risk may cause uncomfortable volatility
- ✗
Large Position Traders
Lower liquidity may impact execution
Consider These Alternatives
If you're interested in ANAB, compare these Health Care peers:
Pro tip: Compare ANAB directly with competitors using our comparison tool to see which stock better fits your criteria.
Get the Full Picture
Access AI-powered insights, DCF valuations, insider trading data, and real-time analysis for ANAB
Frequently Asked Questions
What is ANAB stock price today?
ANAB (Anaptysbio Inc) stock is trading at $55.67 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).
Is ANAB stock going up or down today?
ANAB stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.
Should I buy ANAB stock now?
The decision to buy ANAB depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.
Is ANAB a buy, hold, or sell right now?
Our AI-powered analysis provides buy/hold/sell recommendations for ANAB based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.
Is ANAB stock overvalued or undervalued?
Use our DCF valuation calculator to determine if ANAB is overvalued or undervalued based on fundamental analysis and future cash flow projections.
What is ANAB's P/E ratio?
P/E ratio data for ANAB will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.
What is ANAB's market cap?
ANAB (Anaptysbio Inc) has a market capitalization of $1.69 billion, making it a small-cap stock.
What is ANAB's price to book ratio?
ANAB trades at a price-to-book (P/B) ratio of 131.64, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.
Deep Dive Analysis
Explore comprehensive analysis tools to make an informed decision about Anaptysbio Inc
Full Stock Analysis
Complete ANAB overview with charts and data
Is ANAB Undervalued?
DCF valuation and intrinsic value analysis
Dividend Analysis
Yield, payout ratio, and dividend history
Growth Analysis
Revenue, earnings, and expansion metrics
Financial Health
Debt, liquidity, and balance sheet strength
Price Prediction
2026 forecast and price targets
Stock Forecast
12-month price forecast and analyst targets
Earnings Date
Next earnings date and historical results
Compare Before You Buy
See how ANAB stacks up against its competitors
Similar Investment Decisions
Explore investment analyses for stocks similar to Anaptysbio Inc
Complete ANAB Analysis
Compare ANAB With
Disclaimer
This analysis is for informational purposes only and should not be considered financial advice. The decision score and recommendations are based on quantitative factors and do not account for all risks, your personal financial situation, or qualitative factors. Always do your own research and consider consulting with a financial advisor before making investment decisions.